DeLauro Responds to Mylan’s Settlement with the Department of Justice
WASHINGTON, DC (August 18, 2017) — Congresswoman Rosa DeLauro (CT-03) today released the following statement in response to Mylan’s settlement agreement with the Department of Justice. Mylan, best known as the maker of the EpiPen, will pay federal authorities $465 million for overcharging the Medicaid program.
“The settlement announced by the Department of Justice is an insult to American taxpayers and is barely one-third of what it should be. Last year, the HHS Inspector General found that Mylan overcharged the Medicaid program $1.27 billion for EpiPens,” said DeLauro. “This is just the latest example of the Trump administration advocating for the interest of their corporate constituents while people get shortchanged. With this settlement, the administration is encouraging more price gouging of life-saving drugs that many American children and families need every day.”
DeLauro is the senior Democrat on the subcommittee responsible for funding the Department of Health and Human Services.